Built for Men: The Hidden Gap in Women's Healthcare

International Women’s Day is often filled with celebration; achievements, leadership, progress. But it’s also a timely reminder to look at where gaps still exist.

One of those gaps sits quietly in our healthcare system.

Across Australia, women are navigating menopause, endometriosis and other women's centric conditions within a system that historically wasn’t designed around female biology. While progress has been made, many women still report feeling dismissed, under-researched or under-supported. And they're not wrong. Women's concerns are often misdiagnosed or dismissed due to lack of research.

A System Built on Incomplete Data

For much of modern medical history, clinical research focused predominantly on male bodies. Hormonal cycles were considered too complex to account for, and concerns about pregnancy risks led to the exclusion of many women from early drug trials.

Although policies have changed over time, the legacy of that exclusion remains.

Research from the Australian National University has found that women are significantly more likely to experience adverse reactions to prescription medications than men. Differences in body composition, hormone levels, metabolic function and iron status all influence how drugs are absorbed and processed.

When dosing guidelines and safety data are built primarily around male physiology, women can pay the price.

This imbalance contributes to what is increasingly described as a “women’s health gap”, where symptoms are misinterpreted, diagnoses are delayed, and lived experiences are minimised.

Menopause: A Major Life Stage, Not a Minor Issue

Menopause affects every woman who lives long enough to reach it. In Australia, that’s a significant portion of the population, often at the peak of their careers, caregiving responsibilities and community leadership.

Yet many women report feeling unprepared for the transition.

Menopause and perimenopause can bring:

• Sleep disruption
• Anxiety or low mood
• Brain fog
• Joint discomfort
• Changes in metabolism
• Hot flushes and night sweats

Despite how common these experiences are, women frequently describe feeling dismissed or told to “just push through.” The overall experience is that physicians are unable to provide the support necessary to navigate this journey.

In workplace settings, symptoms can affect confidence and productivity, yet open conversations remain limited. Research highlights how disruptive unmanaged symptoms can be. A large UK survey of 4,000 women found that nearly half felt menopause negatively affected their work, and one in ten left their jobs because of symptoms.

While Australian-specific workplace data is still emerging, the demographic reality is clear: women aged 45–64 are one of the fastest-growing workforce groups. When menopause is poorly understood or unsupported, the economic and social ripple effects are significant.

Menopause is not an illness. It is a biological transition driven by declining oestrogen and progesterone levels. But natural does not mean easy, and it does not mean support isn’t needed.

Improved education, research and workplace awareness are essential to ensuring women don’t have to navigate this phase alone.

Endometriosis: Common, Yet Often Delayed in Diagnosis

Endometriosis affects approximately 1 in 7 Australian women by age 44. It is a chronic inflammatory condition that can cause severe pelvic pain, fatigue, fertility challenges and significant disruption to daily life.

However, diagnosis is often delayed by 6–8 years, meaning many women experience symptoms for years before receiving formal recognition of the condition.

Globally, diagnosis can take years. During that time, symptoms are often minimised, framed as “normal period pain,” stress-related, or exaggerated. For many, the delay means prolonged suffering, repeated medical appointments and escalating impacts on work, education and mental health.

Funding patterns reveal a broader imbalance.

Between 2019 and 2023, 11 start-ups focused on erectile dysfunction and men’s wellness raised $1.24 billion, while just eight start-ups working on endometriosis secured $44 million in the same period. The stark difference underscores how investment in female-specific conditions continues to lag, despite the millions of women affected and the significant impact on their lives.

The contrast is stark.

This isn’t about diminishing men’s health concerns. It’s about recognising that female-specific conditions, even those affecting one in seven women, have historically received less financial backing, slower research progress and delayed diagnostic pathways.

When funding lags, innovation lags. When innovation lags, women wait.

And many are still waiting.

Why Hormonal Health Deserves Greater Focus

Hormones influence nearly every system in the body; mood, sleep, metabolism, immune function, cardiovascular health and cognitive clarity.

When hormonal shifts occur, whether during perimenopause, menopause or in conditions like endometriosis, the effects ripple far beyond the reproductive system.

Yet women are often left piecing together information themselves: through online forums, social media, podcasts and peer conversations. Access to clear, evidence-based, Australian-specific guidance is still inconsistent.

Addressing the women’s health gap requires:

• Sex-specific medical research
• Faster diagnostic pathways
• Better education in schools about menstrual and hormonal health
• Workplace policies that acknowledge menopause
• Ongoing public funding for female-specific conditions

The Cultural Shift We Still Need

Australia has made progress. Women are increasingly advocating for themselves. Conversations about menopause are entering mainstream media. Endometriosis is receiving more national attention. But awareness alone isn’t enough.

Real change means designing healthcare systems and research frameworks with female biology at the centre, not as a variation of the male model.

It also means listening carefully when women describe their symptoms. Not reframing them as stress. Not minimising them. Not defaulting to “normal.”

Moving Forward

Closing the women’s health gap isn’t about comparison with men. It’s about equity, ensuring research, policy and clinical care reflect the biological realities of half the population.

This International Women’s Day, celebration and advocacy can coexist.

We can honour women’s achievements while also acknowledging that menopause deserves structured support. That endometriosis deserves timely diagnosis. That medication research must account for sex differences. That hormonal health is foundational, not niche.

Progress begins with informed conversation, and continues with sustained action.